Precision medicine for age-related macular degeneration: current developments and prospects-Reference-Cited by-同舟云学术

Precision medicine for age-related macular degeneration: current developments and prospects

Published:2018-07-04 Issue:4 Volume:3 Page:249-263
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Biarnés Marc¹,Vassilev Vassil²,Nogoceke Everson³,Emri Eszter²,Rodríguez-Bocanegra Eduardo¹,Ferraro Lucia¹,Garcia Míriam¹,Fauser Sascha³,Monés Jordi¹,Lengyel Imre²,Peto Tunde²

Affiliation:

1. Barcelona Macula Foundation, Barcelona, Spain

2. School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, Belfast, UK

3. Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland

Funder

European Institute of Innovation and Technology’s Horizon 2020 research and innovation program

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2018.1502037

Reference168 articles.

1. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis

2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

3. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis

4. Nature and nurture- genes and environment- predict onset and progression of macular degeneration

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration;International Journal of Biological Macromolecules;2021-11

2. Metabolomics and Age-Related Macular Degeneration;Metabolites;2018-12-27